retatrutide phase 3 triumph 3: Program Results 2026 Retatrutide produces up to 30.3%

During the consumption period, 8.5 g of d-allulose was consumed by the participants before iftar meal

The Medicines and Healthcare products Regulatory Agency (MHRA) has warned healthcare professionals to be aware of the potential risk of pulmonary aspiration in patients using glucagon-like peptide-1 (GLP-1) or dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists (GLP-1 RAs), who undergo surgery or procedures with general anaesthesia or deep sedation

However, one important endpoint that was not reported in the PR is the change to muscle mass

Notably, the $500 range is also the amount manufacturers offer for self-pay obesity patients, raising important questions about whether these programs are truly benefiting those who need them most5,6

Is Retatrutide better than Zepbound